{
    "id": "340462fa-5523-448e-e063-6294a90a4eab",
    "indications": "cardizem indicated management chronic stable angina angina due coronary artery spasm .",
    "contraindications": "exertional angina pectoris due atherosclerotic coronary artery disease angina pectoris rest due coronary artery spasm : must adjusted patient ’ needs . starting 30 mg four times daily , meals bedtime , increased gradually ( given divided doses three four times daily ) 1- 2-day intervals optimum response obtained . although individual patients may respond level , average optimum range appears 180 360 mg/day . available data concerning requirements patients impaired renal hepatic function . must used patients , titration carried particular caution . concomitant cardiovascular agents sublingual ntgmay taken required abort acute anginal attacks cardizem ( diltiazem hydrochloride ) therapy . prophylactic nitrate therapy.cardizem may safely coadministered short- long-acting nitrates , controlled evaluate antianginal effectiveness combination . beta-blockers . ( . ) 30 mg – cardizem tablets may swallowed whole , crushed , chewed . split cardizem tablets . 60 mg , 90 mg , 120 mg – cardizem tablets may swallowed whole , crushed , chewed .",
    "warningsAndPrecautions": "cardizem 30 mg tablets supplied bottles 100 ( ndc 0187-0771-47 ) 500 ( ndc 0187-0771-55 ) . light green , round tablet engraved marion one side 1771 . cardizem 60 mg scored tablets supplied bottles 100 ( ndc 0187-0772-47 ) 500 ( ndc 0187-0772-55 ) . light yellow , round tablet engraved marion one side 1772 . cardizem 90 mg scored tablets supplied bottles 100 ( ndc 0187-0791-47 ) 500 ( ndc 0187-0791-55 ) . light green , capsule-shaped tablet engraved cardizem one side 90 mg . cardizem 120 mg scored tablets supplied bottles 100 ( ndc 0187-0792-47 ) . yellow , capsule-shaped tablet engraved cardizem one side 120 mg . store 25°c ( 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . avoid excessive humidity .",
    "adverseReactions": "cardizem contraindicated : patients sick sinus syndrome except presence functioning ventricular pacemaker patients second- third-degree av block except presence functioning ventricular pacemaker patients hypotension ( less 90 mm hg systolic ) patients demonstrated hypersensitivity patients acute myocardial infarction pulmonary congestion documented x-ray admission",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "LACTOSE, UNSPECIFIED FORM",
            "code": "J2B2A4N98G"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "9XZ8H6N6OH"
        },
        {
            "name": "DILTIAZEM HYDROCHLORIDE",
            "code": "OLH94387TE"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        }
    ],
    "organization": "Bausch Health US LLC",
    "name": "Cardizem",
    "effectiveTime": "20250430",
    "indications_original": "CARDIZEM is indicated for the management of chronic stable angina and angina due to coronary artery spasm.",
    "contraindications_original": "Exertional Angina Pectoris Due to Atherosclerotic Coronary Artery Disease or Angina Pectoris at Rest Due to Coronary Artery Spasm:Dosage must be adjusted to each patient’s needs. Starting with 30 mg four times daily, before meals and at bedtime, dosage should be increased gradually (given in divided doses three or four times daily) at 1- to 2-day intervals until optimum response is obtained. Although individual patients may respond to any dosage level, the average optimum dosage range appears to be 180 to 360 mg/day. There are no available data concerning dosage requirements in patients with impaired renal or hepatic function. If the drug must be used in such patients, titration should be carried out with particular caution.\n\n \n                  \n                     Concomitant Use with Other Cardiovascular Agents\n                  \n                  \n                     \n                        Sublingual NTGmay be taken as required to abort acute anginal attacks during CARDIZEM (diltiazem hydrochloride) therapy.\n \n  \n                     \n                        Prophylactic Nitrate Therapy.CARDIZEM may be safely coadministered with short- and long-acting nitrates, but there have been no controlled studies to evaluate the antianginal effectiveness of this combination.\n \n  \n                     \n                        Beta-blockers.(see\n  \n   \n                           WARNINGS\n                        and\n  \n   \n                           PRECAUTIONS.\n  \n   )\n \n  \n                     30 mg – CARDIZEM tablets may be swallowed whole, crushed, or chewed. Do not split CARDIZEM tablets.\n                     60 mg, 90 mg, and 120 mg – CARDIZEM tablets may be swallowed whole, crushed, or chewed.",
    "warningsAndPrecautions_original": "CARDIZEM 30 mg tablets are supplied in bottles of 100 (NDC 0187-0771-47) and 500 (NDC 0187-0771-55). Each light green, round tablet is engraved with MARION on one side and 1771 on the other.\n                  CARDIZEM 60 mg scored tablets are supplied in bottles of 100 (NDC 0187-0772-47) and 500 (NDC 0187-0772-55). Each light yellow, round tablet is engraved with MARION on one side and 1772 on the other.\n                  CARDIZEM 90 mg scored tablets are supplied in bottles of 100 (NDC 0187-0791-47) and 500 (NDC 0187-0791-55). Each light green, capsule-shaped tablet is engraved with CARDIZEM on one side and 90 mg on the other.\n                  CARDIZEM 120 mg scored tablets are supplied in bottles of 100 (NDC 0187-0792-47). Each yellow, capsule-shaped tablet is engraved with CARDIZEM on one side and 120 mg on the other.\n                  Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Avoid excessive humidity.",
    "adverseReactions_original": "CARDIZEM is contraindicated in:\n                  \n                     Patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker\n                     Patients with second- or third-degree AV block except in the presence of a functioning ventricular pacemaker\n                     Patients with hypotension (less than 90 mm Hg systolic)\n                     Patients who have demonstrated hypersensitivity to the drug\n                     Patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission"
}